Gangwon, South Korea

Min Woo Kim

This inventor holds 1 USPTO granted patent. Top assignee: Immunemed Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Woo Kim. Retrieved from https://idiyas.com/inventor/min-woo-kim-m1ur7lwh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Woo Kim - Innovator in Antibody Development

Introduction

Min Woo Kim is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions for treating viral and inflammatory diseases.

Latest Patents

Min Woo Kim holds a patent for an antibody specifically binding to an isolated peptide derived from vimentin. This invention relates to an antibody that binds to the peptide of SEQ ID NO: 1. The patent encompasses a polynucleotide encoding the antibody, a vector containing the polynucleotide, and a method for producing the antibody using a cell introduced with the vector. Additionally, it includes an antiviral composition and a composition for preventing or treating inflammatory diseases.

Career Highlights

Min Woo Kim is currently associated with Immunemed Inc., where he continues to advance his research and development efforts. His innovative work has the potential to impact the treatment of various infectious viral diseases and inflammatory conditions.

Collaborations

He collaborates with talented coworkers, including Yoon Won Kim and Young Jin Kim, who contribute to the research and development initiatives at Immunemed Inc.

Conclusion

Min Woo Kim's contributions to antibody development highlight his role as a key innovator in biotechnology. His patent and ongoing research efforts are paving the way for new therapeutic approaches to combat viral and inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…